Researching breathlessness in palliative care: Consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup

Palliative Medicine

Volumn 23, Issue 3, 2009, Pages 213-227

  Dorman, Saskie ^a   Jolley, C ^b   Abernethy, A ^c   Currow, D ^d   Johnson, M ^e   Farquhar, M ^f   Griffiths, G ^g   Peel, T ^h   Moosavi, S ⁱ   Byrne, A ^j,n   Wilcock, A ^k   Alloway, L ^l   Bausewein, C ^b   Higginson, I ^b   Booth, S ^m  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d FLINDERS UNIVERSITY   (Australia)

^e UNIVERSITY OF HULL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^j Marie Curie Centre   (United Kingdom)

^k NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^l North Hampshire Palliative Care Service   (United Kingdom)

^m CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁿ Wales Cancer Trials Unit   (United Kingdom)

more..

Author keywords

Breathlessness; Dyspnoea; Measurement; Methodology; Palliative care; Research design

Indexed keywords

MORPHINE; OXYGEN;

ARTICLE; CAREGIVER; CLINICAL TRIAL; CONSENSUS; DISEASE SEVERITY; DYING; DYSPNEA; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; LUNG CAPACITY; MEDICAL RESEARCH; ORGANIZATION; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; STANDARDIZATION;

EID: 63549149149     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309102520     Document Type: Article

References (163)

1. Dudgeon DJ, Kristjanson L, Sloan JA, Lertzman M, Clement K. Dyspnea in cancer patients: Prevalence and associated factors. J Pain Symptom Manage 2001; 21(2): 95-102.
2. Heyse-Moore LH, Ross V, Mullee MA. How much of a problem is dyspnoea in advanced cancer? Palliat Med 1991; 5: 20-26.
3. Nordgren L, Sorensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2003; 2: 213-217.
4. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA. Impact of COPD in North America and Europe in 2000: Subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799-805.
5. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17: 954-961.
6. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: A systematic review. Adv Chronic Kidney Dis 2007; 14: 82-99.
7. American Thoracic Society. Dyspnea: Mechanisms, assessment, and management: A consensus statement. Am J Respir Crit Care Med 1999; 159: 321-340.
8. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: Using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1: 337-344.
9. Booth S, Moosavi S, Higginson I. The etiology and management of intractable breathlessness in patients with advanced cancer: A systematic review of pharmacological therapy. Nat Clin Pract Oncol 2008; 5: 90-100.
10. Roberts DK Thorne SE Pearson C. The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives. Cancer Nurs 1993; 16: 310-320.
11. Stroemgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjogren P. Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage 2002; 21: 189-196.
12. Booth S. Improving research methodology in breathlessness: A meeting convened by the MRC. Palliat Med 2006; 20: 219-220.
13. Jennings AL, Davies AN, Higgins JPT, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews 2001, issue 3, Art. No. CD002066. DOI: 10.1002/ 14651858.CD002066.
14. Guz A. Brain, breathing and breathlessness. Respir Physiol 1997; 109: 197-204.
15. O'Donnell D, Banzett R, Carrieri-Kohlman V, Casaburi R, Davenport P, Gandevia S. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc 2007; 4: 145-168.
16. Killian K, Campbell M. Dyspnea. In: C Roussos, (ed). The Thorax. New York: Marcel Dekker, 1995. p. 1709-1747.
17. Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med 1995; 333: 1547-1553.
18. Killian K, Gandevia S, Summers E, Campbell E. Effect of increased lung volume on perception of breathlessness, effort, and tension. J Appl Physiol 1984; 57: 686-691.
19. Polkey M. Muscle metabolism and exercise tolerance in COPD. Chest 2002; 121(5 Suppl): 131S-135S.
20. Adams L, Lane R, Shea S, Cockcroft A, Guz A. Breathlessness during different forms of ventilatory stimulation: A study of mechanisms in normal subjects and respiratory patients. Clin Sci (Lond) 1985; 69: 663-672.
21. Campbell EJ, Howell JB. The sensation of breathlessness. Br Med Bull 1963; 19: 36-40.
22. Shea S, Banzett R. Respiratory sensations and their role in the control of breathing. In: L Adams, A Guz, (eds). Respiratory sensation. New York: Dekker; 1995. p. 923-957.
23. Evans KC, Banzett RB, Adams L, McKay L, Frackowiak RSJ, Corfield DR. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002; 88: 1500-1511.
24. Parsons LM, Egan G, Liotti M, Brannan S, Denton D, Shade R. Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air. Proc Natl Acad Sci U S A 2001; 98: 2041-2046.
25. von Leupoldt A, Dahme B. Cortical substrates for the perception of dyspnea. Chest 2005; 128: 345-354.
26. von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008; 177: 1026-1032.
27. Kendall M, Harris F, Boyd K, Sheikh A, Murray S, Brown D. Key challenges and ways forward in researching the "good death": Qualitative in-depth interview and focus group study. BMJ 2007; 334: 521-526.
28. Riley J, Ross J. Research into care at the end of life. Lancet 2005; 365: 735-737.
29. Addington-Hall J. Research sensitivities to palliative care patients. Eur J Cancer Care 2002; 11: 220-224.
30. Ewing G, Rogers M, Barclay S, McCabe J, Martin A, Todd C. Recruiting patients into a primary care based study of palliative care: Why is it so difficult? Palliat Med 2004; 18: 452-459.
31. Bakitas M, Lyons K, Dixon J, Ahles T. Palliative care program effectiveness research: Developing rigor in sampling design, conduct, and reporting. J Pain Symptom Manage 2006; 31: 270-284.
32. Jordhoy M, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M. Challenges in palliative care research; recruitment, attrition and compliance: Experience from a randomized controlled trial. Palliat Med 1999; 13: 299-310.
33. Steinhauser K, Clipp E, Hays J, Olsen M, Arnold R, Christakis N. Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006; 20: 745-754.
34. Cook A, Finlay A, Butler-Keating R. Recruiting into palliative care trials: Lessons learnt from a feasibility study. Palliat Med 2002; 16: 163-165.
35. Henderson M, Addington-Hall JM, Hotopf M. The willingness of palliative care patients to participate in research. J Pain Symptom Manage 2005; 29: 116-118.
36. Emanuel E, Fairclough D, Wolfe P, Emanuel L. Talking with terminally ill patients and their caregivers about death, dying, and bereavement: Is it stressful? Is it helpful? Arch Intern Med 2004; 164: 1999-2004.
37. Takesaka J, Crowley R, Casarett D. What is the risk of distress in palliative care survey research? J Pain Symptom Manage 2004; 28: 593-598.
38. Ross C. Cornbleet M. Attitudes of patients and staff to research in a specialist palliative care unit. Palliat Med 2003; 17: 491-497.
39. Seamark D, Gilbert J, Lawrence C, Williams S. Are post-bereavement research interviews distressing to carers? Lessons learned from palliative care research. Palliat Med 2000; 14: 55-56.
40. Davies E, Hall S, Clarke C, Bannon M, Hopkins A. Do research interviews cause distress or interfere in management? Experience from a study of cancer patients. J R Coll Physicians Lond 1998; 32: 406-411.
41. Terry W, Olson L, Ravenscroft P, Wilss L, Boulton-Lewis G. Hospice patients' views on research in palliative care. Int Med J 2006; 36: 406-413.
42. Perkins P, Barclay S, Booth S. What are patients' priorities for palliative care research? Focus group study. Palliat Med 2007; 21: 219-225.
43. Stroemgren AS, Sjogren P, Goldschmidt D, Peterson MA, Pedersen L, Hoermann L. Longitudinal study of palliative care: Patient-evaluated outcome and impact of attrition. Cancer 2005; 103: 1745-1755.
44. Tang ST, McCorkle R. Appropriate time frames for data collection in quality of life research among cancer patients at the end of life. Qual Life Res 2002; 11: 145-155.
45. Rinck GC, van den Bos GA, Kleijnen J, de Haes HJ, Schade E, Veenhof CH. Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol 1997; 15: 1697-1707.
46. Kirkham S, Abel J. Placebo-controlled trials in palliative care: The argument against. Palliat Med 1997; 11: 489-492.
47. Abernethy A, Currow D, Frith P, Fazekas B, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523-528.
48. www.mrc.ac.uk/complexinterventionsguidance
49. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008; 337: A1655.
50. Richardson W, Wilson M, Nishikawa J, Hayward R. The well-built clinical question: A key to evidence-based decisions [editorial]. ACP Journal Club 1995; 123: A12-A13.
51. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M. Suggested format for research recommendations on the effects of treatments. BMJ 2006; 333: 804-806.
52. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
53. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008; 337: A2390.
54. Williams SJ, Bury MR. Impairment, disability and handicap in chronic respiratory illness. Soc Sci Med 1989; 29: 609-616.
55. http://www.brit-thoracic.org.uk/LibraryGuidelines/BTSPublications/ BurdenofLungDiseaseReports/tabid/164/Default.aspx
56. Hardie GE, Janson S, Gold WM, Carrieri-Kohlman V, Boushey HA. Ethnic differences: Word descriptors used by African-American and white asthma patients during induced bronchoconstriction. Chest 2000; 117: 935-943.
57. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a Combined Comorbidity Index. J Clin Epidemiol 1994; 47: 1245-1251.
58. Heyse-Moore LH. On dyspnoea in advanced cancer [DM]. Southampton University; 1993.
59. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
60. Medical Research Council. Questionnaire on Respiratory Symptoms. London: Publications Group, Medical Research Council; 1986.
61. Fairburn AJ, Wood CH, Fletcher CM. Variability in answers to a questionnaire on respiratory symptoms. Br J Prev Soc Med 1959; 13: 175-193.
62. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2: 257-266.
63. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustard in the palliative treatment of cancer. Cancer 1948; 1: 634-656.
64. Abernethy A, Shelby-James T, Fazekas B, Woods D, Currow D. The Australia-modified Karnofsky Performance Status (AKPS) Scale: A revised scale for contemporary palliative care clinical practice. BMC Palliat Care 2005; 4: 7.
65. Simon PM, Schwartzstein RM. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989; 140: 1021-1027.
66. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 142: 1009-1014.
67. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Development and validation of the Cancer Dyspnoea Scale: A multidimensional, brief, self-rating scale. Br J Cancer 2000; 82: 800-805.
68. Parshall MB. Psychometric characteristics of dyspnea descriptor ratings in emergency department patients with exacerbated chronic obstructive pulmonary disease. Res Nurs Health 2002; 25: 331-344.
69. Parshall MB, Welsh JD, Brockopp DY, Heiser RM, Schooler MP, Cassidy KB. Reliability and validity of dyspnea sensory quality descriptors in heart failure patients treated in an emergency department. Heart Lung 2001; 30: 57-65.
70. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998; 7: 200-204.
71. Wilcock A, Crosby V, Clarke D, Tattersfield A. Repeatability of breathlessness measurements in cancer patients. Thorax 1999; 54: 375.
72. Borg G. A category scale with ratio properties for intermodal and intervindividual comparisons. In: HG Geissler, T Petzoldt, (eds). Psychophysical judgements and the process of perception. Berlin: Deutscher Verlag; 1982.
73. Eakin EG, Sassi-Dambron EE, Ries AL, Kaplan RL. Reliability and validity of dyspnoea measures in patients with obstructive lung disease. Int J Behav Med 1995; 2: 118-134.
74. Powers J, Bennett SJ. Measurement of dyspnea in patients treated with mechanical ventilation. Am J Crit Care 1999; 8: 254-261.
75. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
76. The EuroQol Group. EuroQol: A new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208.
77. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy - Lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199-220.
78. Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A. The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care. Eur J Cancer 2006; 42: 55-64.
79. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994; 30A: 635-642.
80. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson I. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: A qualitative phase 1 study. Palliat Support Care 2006; 4: 287-293.
81. Booth S, Adams L. The shuttle walking test: A reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer. Thorax 2001; 56: 146-150.
82. Wilcock A, Crosby V, Clarke D, Corcoran R, Tattersfield A. Reading numbers aloud: A measure of the limiting effect of breathlessness in patients with cancer. Thorax 1999; 54: 1099-1103.
83. Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med 1995; 89: 291-296.
84. Dudgeon DJ, Lertzman M. Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998; 16: 212-219.
85. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
86. Skevington SM, Pilaar M, Routh D, Macleod RD. On the language of breathlessness. Psychol Health 1997; 12: 677-689.
87. Wilcock A, Crosby V, Hughes A, Fielding K, Corcoran R, Tattersfield AE. Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases. J Pain Symptom Manage 2002; 23: 182-189.
88. Henoch I, Bergman B, Gaston-Johansson F. Validation of a Swedish version of the Cancer Dyspnea Scale. J Pain Symptom Manage 2006; 31: 353-361.
89. Campbell M, Fitzpatrick R, Haines A, Kinmonth A, Sandercock P, Spiegelhalter D. Framework for design and evaluation of complex interventions to improve health. BMJ 2000; 321: 694-696.
90. Booth S, Kelly MJ, Cox NP, Adams L, Guz A. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med 1996; 153: 1515-1518.
91. Uronis H, Currow D, McCrory D, Samsa G, Abernethy A. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: A systematic review and meta-analysis. Br J Cancer 2008; 98: 294-299.
92. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999; 318: 901-904.
93. Hately J, Laurence V, Scott A, Baker R, Thomas P. Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliat Med 2003; 17: 410-417.
94. Streiner DL, Norman GR. Health measurement scales. 3rd ed. New York: Oxford University Press; 2003.
95. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2: 92-98.
96. Martinez JA, Straccia L, Sobrani E, Silva GA, Vianna EO, Filho JT. Dyspnea scales in the assessment of illiterate patients with chronic obstructive pulmonary disease. Am J Med Sci 2000; 320: 240-243.
97. Lacasse Y, Wong E, Guyatt GH. A systematic overview of the measurement properties of the chronic respiratory questionnaire. Can Respir J 1997; 4: 131-139.
98. Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001; 56: 954-959.
99. Williams JE, Singh SJ, Sewell L, Morgan MD. Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 2003; 58: 515-518.
100. Puhan MA, Behnke M, Laschke M, Lichtenschopf A, Brandli O, Guyatt GH. Self-administration and standardisation of the chronic respiratory questionnaire: A randomised trial in three German-speaking countries. Respir Med 2004; 98: 342-350.
101. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Austin P. A comparison of the original chronic respiratory questionnaire with a standardized version. Chest 2003; 124: 1421-1429.
102. Dougan CF, Connell CO, Thornton E, Young CA. Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS). J Neurol Sci 2000; 180: 86-93.
103. Fitzpatrick R, Davey C, Buxton M, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 1-74.
104. Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; 19: 357-362.
105. Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage 2001; 21: 373-379.
106. Wilcock A, Maddocks M, Lewis M, England R, Manderson C. Symptoms limiting activity in cancer patients with breathlessness on exertion: ask about muscle fatigue. Thorax 2008; 63: 91-92.
107. Guyatt GH, Townsend M, Berman LB, Pugsley SO. Quality of life in patients with chronic airflow limitation. Br J Dis Chest 1987; 81: 45-54.
108. von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary disease. Respir Med 2007; 101: 411-422.
109. Magnusson S, Gislason T. Chronic bronchitis in Icelandic males: prevalence, sleep disturbances and quality of life. Scand J Prim Health Care 1999; 17: 100-104.
110. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007; 21: 177-191.
111. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ. Measurement of breathlessness in advanced disease: A systematic review. Respirat Med 2007; 101: 399-410.
112. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality of life instruments: Attributes and review criteria. Qual Life Res 2002; 11: 193-205.
113. Ries AL. Minimally Clinically Important Difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD: J Chron Obstruct Pulmon Dis 2005; 2: 105-110.
114. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NMB, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997; 52: 879-887.
115. Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: Conclusions from a randomized control trial. Respirat Med 1989; 83: 293-297.
116. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(3Pt 1): 785-790.
117. Wijkstra PJ, TenVergert EM, Van Altena R, Otten V, Postma DS, Kraan J. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994; 49: 465-467.
118. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175-1182.
119. Bradley J, Dempster M, Wallace E, Elborn S. The adaptations of a quality of life questionnaire for routine use in clinical practice: The Chronic Respiratory Disease Questionnaire in cystic fibrosis. Qual Life Res 1999; 8: 65-71.
120. Knebel AR, Leidy NK, Sherman S. Health related quality of life and disease severity in patients with alpha-1 antitrypsin deficiency. Qual Life Res 1999; 8: 385-391.
121. Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989; 4: 101-107.
122. Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD 2005; 2: 81-89.
123. Joyce C, McGee H, O'Boyle C. Individual quality of life: Approaches to conceptualisation and assessment. Amsterdam: Harwood Academic Publishers; 1999.
124. Bowling A. Measuring Disease. A review of disease-specific quality of life measurement scales. 2nd ed. Buckingham, UK: Open University Press; 2001.
125. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ. The Euorpean Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
126. Farquhar M, Higginson IJ, Booth S. Repeated measurement of quality of life in palliative care research: The experience of using the SEIQoL-DW in a pilot Phase II RCT of a complex intervention for breathlessness. Palliat Med 2008; 22: 589-603.
127. Bernhard J. Timing of quality of life assessment in cancer clinical trials: Fine tuning remains a challenge. Ann Oncol 2005; 16: 523-524.
128. Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989; 96: 1247-1251.
129. Eakin EG, Kaplan RM, Ries AL, Sassi-Dambron DE. Patients' self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease. Ann Behav Med 1996; 18: 87-90.
130. Executive Summary. Global Strategy for the Diagnosis, Management, and Prevention of COPD Revised 2006. Am J Respir Crit Care Med 2007; 176: 532-555.
131. Eakin EG, Kaplan RM, Ries AL. Measurement of dyspnoea in chronic obstructive pulmonary disease. Qual Life Res 1993; 2: 181-191.
132. O'Donnell D, Webb K. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357.
133. O'Donnell D, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD 2007; 4: 225-236.
134. O'Donnell D, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-777.
135. O'Donnell D, Fluge T, Gerken F. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840.
136. O'Donnell D, Hamilton A, Webb K. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006; 101: 1025-1035.
137. American Thoracic Society, European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166: 518-624.
138. Steier J, Kaul S, Seymour J, Jolley C, Rafferty G, Man W. The value of multiple tests of respiratory muscle strength. Thorax 2007; 62: 975-980.
139. Hughes P, Polkey M, Kyroussis D, Hamnegard C, Moxham J, Green M. Measurement of sniff nasal and diaphragm twitch mouth pressure in patients. Thorax 1998; 53: 96-100.
140. Edgecombe J, Wilcock A, Carr D, Clarke D, Corcoran R, Tattersfield A. Re: Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1999; 18: 313-315.
141. Feathers L, Wilcock A, Manderson C, Weller R, Tattersfield AE. Measuring inspiratory muscle weakness in patients with cancer and breathlessness. J Pain Symptom Manage 2003; 25: 305-306.
142. Wilson R, Jones P. Influence of prior ventilatory experience on the estimation of breathlessness during exercise. Clin Sci 1980; 78: 149-153.
143. Pino-Garcia J, Garcia-Rio F, Gomez L, Racionero M, Diaz-Lobato S, Villamor J. Short-term effects of inhaled beta-adrenergic agonist on breathlessness and central inspiratory drive in patients with nonreversible COPD. Chest 1996; 110: 637-641.
144. Sinderby C, Spahija J, Beck J, Kaminski D, Yan S, Comtois N. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-1641.
145. Duiverman M, van Eykern L, Vennik P, Koeter G, Maarsingh E, Wijkstra P. Reproducibility and responsiveness of a noninvasive EMG technique of the respiratory muscles in COPD patients and in healthy subjects. J Appl Physiol 2004; 96: 1723-1729.
146. Ward M, Eidelman D, Stubbing D, Bellemare F, Macklem P. Respiratory sensation and pattern of respiratory muscle activation during diaphragm fatigue. J Appl Physiol 1988; 65: 2181-2189.
147. Schellart N, Reits D. Voluntary breath holding affects spontaneous brain activity measured by magnetoencephalography. Undersea Hyperb Med 1999; 26: 229-234.
148. Palange P, Ward S, Carlsen K-H, Casaburi R, Gallagher C, Gosselink R. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185-209.
149. Hamilton AL, Killian KJ, Summers E, Jones NL. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996; 110: 1255-1263.
150. Wilcock A, Walker G, Manderson C, Carr D, Broadhurst D, Crosby V. Use of upper limb exercise to assess breathlessness in patients with cancer: tolerability, repeatability, and sensitivity. J Pain Symptom Manage 2005; 29: 559-564.
151. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-270.
152. Brown C, Wise R. Field Tests of Exercise in COPD: The Six-Minute Walk Test and the Shuttle Walk Test. COPD 2007; 4: 217-223.
153. Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213-222.
154. O'Keeffe ST, Lye M, Donnellan C, Carmichael DN. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998; 80: 377-382.
155. Guyatt GH, Sullivan MJ, Fallen EL, Thompson PJ, Pugsley SO, Taylor DW. The six minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-923.
156. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
157. Guyatt GH, Pugsley SO, Sullivan MJ. Effect of encouragement on walking test performance. Thorax 1984; 39: 818-822.
158. Maddocks M, Wilcock A, Mockett S. Re: the effect of a physical exercise program in palliative care: a phase II study. J Pain Symptom Manage 2006; 32: 513-515.
159. Gysels M, Bausewein C, Higginson I,. Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Support Care 2007; 5: 281-302.
160. Smith J. Qualitative research in psychology. London: Sage; 2003.
161. Ritchie J, Lewis J. Qualitative research practice. London, Thousand Oaks, New Delhi: Sage Publications Limited; 2003.
162. Currow D, Agar M, Tieman J, Abernethy A. Multisite research allows adequately powered palliative care trials; web-based data management makes it achievable today. Palliat Med 2008; 22: 91-92.
163. http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/ GoodClinicalPractice/index.htm